Saturday, September 12, 2020 9:55:10 PM
Please do note, I'm not delusional, I know they don't get two poops about us, less so now that they pulled that secondary and have money to burn.
Dear Mr. Schulman,
It's hard to get an answer from you, that's for sure! I'm not sure how many attempts I've taken, but it seems that you're way too busy to answer me. Please let me know, since you do work for me, you are aware of that; aren't you, you work for the shareholder, exactly what it is that you are doing that keeps you from addressing my issues, or any other shareholder's issues, for that matter?
I'm a bit concern that perhaps you aren't following my thought process, I've bought before the pandemic (which was your clue that I bought high) or at least before the market in general realized that Aurinia wasn't worth what I had paid for it, perhaps, that's because further shareholders had they tried to get an answer from Investor's Relation got the same thing that I got from you, zilch, nada, or a big fat goose egg.
Clearly, I'm not happy with your performance. Please tell me that you've been on holiday or maybe even paternity leave, something, anything; just don't let me believe you're ignoring shareholders.
Also Mr. Schulman, I'm done thanking you in advance for the time it's taking you to answering me, since you haven't been answering me. I'm just hoping that you do take the time to answer me for I will be perusing it with more senior Aurinia employees, again, I'll remind you, they too, work for the shareholders, just maybe they understand that they work for shareholders and possibly, they'll give me an honest answer. Time will tell.
Sincerely,
Recent AUPH News
- New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference • Business Wire • 04/16/2024 02:48:00 PM
- Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024 • Business Wire • 04/15/2024 10:00:00 AM
- Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference • Business Wire • 04/09/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:44:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:43:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:42:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:41:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:10:10 PM
- Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program • Business Wire • 02/29/2024 01:30:00 PM
- Aurinia to Participate in Upcoming Investor Healthcare Conferences • Business Wire • 02/27/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:35:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:33:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:31:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:29:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:27:55 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 02/22/2024 09:19:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/15/2024 11:16:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 11:06:50 AM
- Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value • Business Wire • 02/15/2024 11:00:00 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:27:55 PM
- Aurinia Pharmaceuticals to Release 2023 Fourth Quarter and Full Year Financial and Operational Results on February 15, 2024 • Business Wire • 02/05/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 11:02:28 AM
- Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue Results • Business Wire • 01/05/2024 11:00:00 AM
- Aurinia Submits IND Application to US Food & Drug Administration for AUR 200 • Business Wire • 12/20/2023 11:00:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM